Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -38.51M | $ -7.44 | 1 | 5.18M |
3/31/2025 | $ -40.1M | $ -11.27 | 1 | 3.56M |
12/31/2024 | $ -37.76M | $ -41.5 | 1 | 909.8K |
9/30/2024 | $ -41.03M | $ -113.78 | 1 | 360.67K |
6/30/2024 | $ -21.73M | $ -60.24 | 1 | 360.67K |
3/31/2024 | $ -21.5M | $ -59.62 | 1 | 360.67K |
12/31/2023 | $ -21.06M | $ -59.44 | 1 | 354.27K |
9/30/2023 | $ -19.96M | $ -55.35 | 1 | 360.67K |
6/30/2023 | $ -21.68M | $ -61.31 | 1 | 353.53K |
3/31/2023 | $ -20.57M | $ -60.18 | 1 | 341.8K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for ERNEXA THERAPEUTICS INC is calculated as follows: EBIT [ $ -5.79M ] / (Shares WA [ 4.89K ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.18K ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.8K |
---|---|
min | $ -9.77 |
max | $ 10.86 |
average | $ 1.17 |
median | $ 0.39 |
std | $ 3.44 |